Progesterone showdown: are two injections equally effective?

NCT ID NCT07495007

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a new injectable progesterone (Prontogest) works the same in the body as the standard progesterone injection. Twenty-six healthy postmenopausal women received single doses of each in a randomized order. The goal was to check if the two formulations are bioequivalent, meaning they produce similar drug levels in the blood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

progesterone injection

What this could lead to

If the test product is shown to be equivalent, it could offer a similar option for progesterone therapy.

What could go wrong

This is a small, early-phase study in healthy volunteers, not patients. Results may not predict real-world use or safety in those needing treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zi Diligence Biocenter

    Cairo, Cairo Governorate, 19653, Egypt